Current Research Competitions


Marshall Eliuk Fund for Clinical Innovation in Hematology - Fall 2017 Competition

 

The University Hospital Foundation and the Division of Hematology, University of Alberta are pleased to announce a Request for Proposals for the Marshall Eliuk Fund for Clinical Innovation in Hematology.

The competition will be funded by a generous donation from Mr. Marshall Eliuk to support clinical research and innovation to be conducted at the University of Alberta. The Division of Hematology will administer the competition.

Learn more about The Marshall Eliuk Fund for Clinical Innovation and Exemplary Care in Hematology.

Objectives:

To provide funding support for the development and establishment of innovative therapies or diagnostic tests in the field of Hematology at the University of Alberta.

Scope of support:

To provide seed funding to develop promising new treatments or diagnostic tests in the field of hematology, that are not currently available for patients with blood disorders in the Edmonton region. This may include:

  1. Translational Research: Essential pre-clinical studies required to develop a novel treatment or diagnostic test. This may include laboratory-based earch studies to establish the efficacy of a potential treatment or diagnostic test, or toxicology studies to evaluate the safety of a potential treatment, with the intention of taking a novel treatment to clinical trial.
  2. Clinical trial: Support for an early phase clinical trial using a novel treatment. This must be a locally developed investigator-initiated project. External industry-sponsored or cooperative group based trials are not eligible.
  3. Pilot project: Support for a pilot project to introduce a new treatment or diagnostic modality currently not available to patients in Edmonton.
  4. Equipment: Purchase of essential equipment or supplies needed to establish a new treatment, or a diagnostic test influencing treatment, that is not currently available in Edmonton.
  5. Quality improvement project designed to improve patient treatment outcomes.

The deadline for receipt of completed applications is November 15, 2017, at 4:00 pm.

 

Download the competition Terms of Reference and Processes 

 

For more information about the competition, please contact:

Gilda Stalker, Executive Administrator, Division of Hematology

4-112 Clinical Sciences Building 11350 – 83 Avenue Edmonton, AB T6G 2G3

gstalker@ualberta.ca


 

Donor Office - University of Alberta Hospital

1H1.91 WMC, 8440 – 112 Street NW, Edmonton, AB T6G 2B7

Donor Office - Mazankowski Alberta Heart Institute

2A9.006 MAHI, 8440 – 112 Street NW, Edmonton, AB T6G 2B7

Donor Office - Kaye Edmonton Clinic

1B.120 KEC, 11400 University Avenue, Edmonton, AB T6G 1Z1

University Hospital Foundation

Phone: 780-407-7007 | Fax: 780-407-6603
uhfoundation@albertahealthservices.ca
Charitable Registration Number  88900-3240 RR0001

 



Copyright 2017 University Hospital Foundation